EMEA-001590-PIP01-13-M04 - paediatric investigation plan

allantoin

Key facts

• Active substance:
  allantoin
• Therapeutic area:
  Dermatology
• Decision number:
  P/0225/2017
• PIP number:
  EMEA-001590-PIP01-13-M04
• Pharmaceutical form(s):
  Cream
• Condition(s) / indication(s):
  Treatment of epidermolysis bullosa
• Route(s) of administration:
  Topical use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  11/08/2017
• Compliance check done:
  No

Decision

P/0225/2017: EMA decision of 11 August 2017 on the acceptance of a modification of an agreed paediatric investigation plan for allantoin (EMEA- 001590-PIP01-13-M04)

Adopted Reference Number: EMA/460043/2017